1 – 10 of 10
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
Integrin α10, a novel therapeutic target in glioblastoma, regulates cell migration, proliferation, and survival
(
- Contribution to journal › Article
- 2016
-
Mark
ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
(
- Contribution to journal › Article
- 2015
-
Mark
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.
(
- Contribution to journal › Article
- 2011
-
Mark
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
(
- Contribution to journal › Article
- 2008
-
Mark
An improved method for detecting and delineating genomic regions with altered gene expression in cancer
(
- Contribution to journal › Article
-
Mark
Models from experiments: combinatorial drug perturbations of cancer cells
(
- Contribution to journal › Article
- 2007
-
Mark
Threshold-free high-power methods for the ontological analysis of genome-wide gene expression studies
(
- Contribution to journal › Article
- 2003
-
Mark
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family.
(
- Contribution to journal › Article